Ledger.Open graph →
SEC Form D · filed April 3, 2024

Mirador Therapeutics, Inc

Offering
$333.0M
Sold
$333.0M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
San Diego, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Scott K. Glenn · San Diego, CADirectorBenjamin Prinzing · FOREST GROVE, ORDirectorChui Tin Mok · GARDENA, CAExecKristina K. Burow · San Diego, CADirectorRodney Cannon · Abu Dhabi, C0DirectorJoseph K. Papa · San Diego, CADirectorVika K. Brough · San Diego, CAExecMark C. Mckenna · San Diego, CAExec · DirectorDavid K. Bonita, M.D · San Diego, CADirectorSabrina Foster · Grand Cayman, Cayman IslandsDirectorJoseph K. Papa · San Diego, CADirectorVika K. Brough · San Diego, CAExecScott K. Glenn · San Diego, CADirectorTimothy K. Andrews · San Diego, CAExecDavid K. Bonita, M.D · San Diego, CADirectorPaul K. Berns · San Diego, CADirectorTimothy K. Andrews · San Diego, CAExecMark C. Mckenna · San Diego, CAExec · DirectorPaul K. Berns · San Diego, CADirectorYueting Jia · GARDENA, CADirectorJie Sheng · GARDENA, CADirectorMatt Auriemma · Grand Cayman, Cayman IslandsExec · DirectorHani Barhoush · Abu Dhabi, C0ExecKristina K. Burow · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗